Phase 3 Transient Ischemic Attack Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 2Phase 3

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Ischemic StrokeTransient Ischemic Attack

Mazandaran University of Medical Sciences100 enrolled1 locationNCT06653348

Recruiting

Phase 3

The effect of Colchicine on Cardiovascular Outcomes in Stroke Study (The CASPER Study)

AtherosclerosisIschemic StrokeTransient Ischemic Attack

University of Sydney1,500 enrolled9 locationsACTRN12621001408875